Trademark: 90095313
Status Date
Tuesday, May 2, 2023
Registration Number
7043514
Registration Date
Tuesday, May 2, 2023
Filing Date
Wednesday, August 5, 2020
Published for Opposition
Tuesday, October 12, 2021
42 Pharmaceutical products development; Pharmaceutical research and development, namely, research in the field of gene editing; Pharmaceutical research services; Biomedical research services; Biotechnology research, namely, in the field of genetic editing; Clinical research in the field of gene editing; Drug discovery services; Medical and scientific research in the field of cancer treatment; Medical and scientific research in the field of treatment of rare genetic diseases and disorders; Medical research; Medical research services, namely, for the treatment of cystic fibrosis and lung cancer; Providing laboratory research services in the field of gene expression, namely, cancer biology; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Research in the field of genetic editing; Research on the subject of pharmaceuticals, namely, pharmaceuticals to treat genetic disorders, cystic fibrosis and lung cancer; Scientific investigations for medical purposes; Scientific research in the field of oncology; Scientific study and research in the field of oncology; Technical consulting in the field of pharmaceutical studies; Technical research in the field of pharmaceutical studies; Medical and scientific research in the field of genetic engineering, namely, platform gene editing technology; Consulting services in the fields of biotechnology, pharmaceutical research and development and genetic science; Providing medical and scientific research information in the fields of pharmaceuticals and genetics; Scientific research in the field of genetics and genetic engineering; Platform as a service (PAAS) featuring computer software platforms for gene editing
May 2, 2023
Notice Of Registration Confirmation Emailed
May 2, 2023
Registered-Principal Register
Mar 25, 2023
Notice Of Acceptance Of Statement Of Use E-Mailed
Mar 24, 2023
Allowed Principal Register - Sou Accepted
Mar 10, 2023
Assigned To Examiner
Jan 17, 2023
Teas/Email Correspondence Entered
Jan 17, 2023
Correspondence Received In Law Office
Jan 17, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jan 17, 2023
Assigned To Lie
Jan 10, 2023
Teas Response To Office Action Received
Jul 17, 2022
Notification Of Non-Final Action E-Mailed
Jul 17, 2022
Non-Final Action E-Mailed
Jul 17, 2022
Su - Non-Final Action - Written
May 16, 2022
Statement Of Use Processing Complete
May 10, 2022
Use Amendment Filed
May 10, 2022
Teas Statement Of Use Received
Dec 16, 2021
Teas Change Of Correspondence Received
Dec 16, 2021
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 16, 2021
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Dec 7, 2021
Noa E-Mailed - Sou Required From Applicant
Oct 12, 2021
Official Gazette Publication Confirmation E-Mailed
Oct 12, 2021
Published For Opposition
Sep 22, 2021
Notification Of Notice Of Publication E-Mailed
Sep 9, 2021
Approved For Pub - Principal Register
Aug 11, 2021
Divisional Processing Complete
May 19, 2021
Divisional Request Received
Aug 2, 2021
Case Assigned To Intent To Use Paralegal
Jul 7, 2021
Assigned To Lie
May 19, 2021
Teas Response To Office Action Received
May 19, 2021
Teas Request To Divide Received
Nov 29, 2020
Notification Of Non-Final Action E-Mailed
Nov 29, 2020
Non-Final Action E-Mailed
Nov 29, 2020
Non-Final Action Written
Nov 28, 2020
Assigned To Examiner
Sep 4, 2020
New Application Office Supplied Data Entered
Aug 8, 2020
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
